Novel synthesis and characterization of an AB-type carbonate-substituted hydroxyapatite

Iain Ronald Gibson, W. Bonfield

Research output: Contribution to journalArticle

315 Citations (Scopus)

Abstract

A novel synthesis route has been developed to produce a high-purity mixed AB-type carbonate-substituted hydroxyapatite (CHA) with a carbonate content that is comparable to the type and level observed in bone mineral. This method involves the aqueous precipitation in the presence of carbonate ions in solution of a calcium phosphate apatite with a Ca/P molar ratio greater than the stoichiometric value of 1.67 for hydroxyapatite (HA). The resulting calcium-rich carbonate-apatite is sintered/heat-treated in a carbon dioxide atmosphere to produce a single-phase, crystalline carbonate-substituted hydroxyapatite. In contrast to previous methods for producing B- or AB-type carbonate-substituted hydroxyapatites, no sodium or ammonium ions, which would be present in the reaction mixture from the sodium or ammonium carbonates commonly used as a source of carbonate ions, were present in the final product. The chemical and phase compositions of the carbonate-substituted hydroxyapatite was characterized by X-ray fluorescence and X-ray diffraction, respectively, and the level and nature of the carbonate substitution were studied using C-H-N analysis and Fourier transform infrared spectroscopy, respectively. The carbonate substitution improves the densification of hydroxyapatite and reduces the sintering temperature required to achieve near-full density by approximately 200 degreesC compared to stoichiometric HA. Initial studies have shown that these carbonate-substituted hydroxyapatites have improved mechanical and biologic properties compared to stoichiometric hydroxyapatite. (C) 2001 John Wiley Sons, Inc.

Original languageEnglish
Pages (from-to)697-708
Number of pages11
JournalJournal of Biomedical Materials Research
Volume59
Issue number4
DOIs
Publication statusPublished - Apr 2002

Keywords

  • hydroxyapatite
  • carbonate
  • synthetic bone graft
  • sintering
  • bioactivity
  • X-RAY-DIFFRACTION
  • APATITES
  • BONE
  • IONS
  • SPECTROSCOPY
  • PARAMETERS

Cite this

Novel synthesis and characterization of an AB-type carbonate-substituted hydroxyapatite. / Gibson, Iain Ronald; Bonfield, W.

In: Journal of Biomedical Materials Research, Vol. 59, No. 4, 04.2002, p. 697-708.

Research output: Contribution to journalArticle

@article{475363f6a4ef437f8bcf099c1b351407,
title = "Novel synthesis and characterization of an AB-type carbonate-substituted hydroxyapatite",
abstract = "A novel synthesis route has been developed to produce a high-purity mixed AB-type carbonate-substituted hydroxyapatite (CHA) with a carbonate content that is comparable to the type and level observed in bone mineral. This method involves the aqueous precipitation in the presence of carbonate ions in solution of a calcium phosphate apatite with a Ca/P molar ratio greater than the stoichiometric value of 1.67 for hydroxyapatite (HA). The resulting calcium-rich carbonate-apatite is sintered/heat-treated in a carbon dioxide atmosphere to produce a single-phase, crystalline carbonate-substituted hydroxyapatite. In contrast to previous methods for producing B- or AB-type carbonate-substituted hydroxyapatites, no sodium or ammonium ions, which would be present in the reaction mixture from the sodium or ammonium carbonates commonly used as a source of carbonate ions, were present in the final product. The chemical and phase compositions of the carbonate-substituted hydroxyapatite was characterized by X-ray fluorescence and X-ray diffraction, respectively, and the level and nature of the carbonate substitution were studied using C-H-N analysis and Fourier transform infrared spectroscopy, respectively. The carbonate substitution improves the densification of hydroxyapatite and reduces the sintering temperature required to achieve near-full density by approximately 200 degreesC compared to stoichiometric HA. Initial studies have shown that these carbonate-substituted hydroxyapatites have improved mechanical and biologic properties compared to stoichiometric hydroxyapatite. (C) 2001 John Wiley Sons, Inc.",
keywords = "hydroxyapatite, carbonate, synthetic bone graft, sintering, bioactivity, X-RAY-DIFFRACTION, APATITES, BONE, IONS, SPECTROSCOPY, PARAMETERS",
author = "Gibson, {Iain Ronald} and W. Bonfield",
year = "2002",
month = "4",
doi = "10.1002/jbm.10044",
language = "English",
volume = "59",
pages = "697--708",
journal = "Journal of Biomedical Materials Research",
issn = "0021-9304",
publisher = "Heterocorporation",
number = "4",

}

TY - JOUR

T1 - Novel synthesis and characterization of an AB-type carbonate-substituted hydroxyapatite

AU - Gibson, Iain Ronald

AU - Bonfield, W.

PY - 2002/4

Y1 - 2002/4

N2 - A novel synthesis route has been developed to produce a high-purity mixed AB-type carbonate-substituted hydroxyapatite (CHA) with a carbonate content that is comparable to the type and level observed in bone mineral. This method involves the aqueous precipitation in the presence of carbonate ions in solution of a calcium phosphate apatite with a Ca/P molar ratio greater than the stoichiometric value of 1.67 for hydroxyapatite (HA). The resulting calcium-rich carbonate-apatite is sintered/heat-treated in a carbon dioxide atmosphere to produce a single-phase, crystalline carbonate-substituted hydroxyapatite. In contrast to previous methods for producing B- or AB-type carbonate-substituted hydroxyapatites, no sodium or ammonium ions, which would be present in the reaction mixture from the sodium or ammonium carbonates commonly used as a source of carbonate ions, were present in the final product. The chemical and phase compositions of the carbonate-substituted hydroxyapatite was characterized by X-ray fluorescence and X-ray diffraction, respectively, and the level and nature of the carbonate substitution were studied using C-H-N analysis and Fourier transform infrared spectroscopy, respectively. The carbonate substitution improves the densification of hydroxyapatite and reduces the sintering temperature required to achieve near-full density by approximately 200 degreesC compared to stoichiometric HA. Initial studies have shown that these carbonate-substituted hydroxyapatites have improved mechanical and biologic properties compared to stoichiometric hydroxyapatite. (C) 2001 John Wiley Sons, Inc.

AB - A novel synthesis route has been developed to produce a high-purity mixed AB-type carbonate-substituted hydroxyapatite (CHA) with a carbonate content that is comparable to the type and level observed in bone mineral. This method involves the aqueous precipitation in the presence of carbonate ions in solution of a calcium phosphate apatite with a Ca/P molar ratio greater than the stoichiometric value of 1.67 for hydroxyapatite (HA). The resulting calcium-rich carbonate-apatite is sintered/heat-treated in a carbon dioxide atmosphere to produce a single-phase, crystalline carbonate-substituted hydroxyapatite. In contrast to previous methods for producing B- or AB-type carbonate-substituted hydroxyapatites, no sodium or ammonium ions, which would be present in the reaction mixture from the sodium or ammonium carbonates commonly used as a source of carbonate ions, were present in the final product. The chemical and phase compositions of the carbonate-substituted hydroxyapatite was characterized by X-ray fluorescence and X-ray diffraction, respectively, and the level and nature of the carbonate substitution were studied using C-H-N analysis and Fourier transform infrared spectroscopy, respectively. The carbonate substitution improves the densification of hydroxyapatite and reduces the sintering temperature required to achieve near-full density by approximately 200 degreesC compared to stoichiometric HA. Initial studies have shown that these carbonate-substituted hydroxyapatites have improved mechanical and biologic properties compared to stoichiometric hydroxyapatite. (C) 2001 John Wiley Sons, Inc.

KW - hydroxyapatite

KW - carbonate

KW - synthetic bone graft

KW - sintering

KW - bioactivity

KW - X-RAY-DIFFRACTION

KW - APATITES

KW - BONE

KW - IONS

KW - SPECTROSCOPY

KW - PARAMETERS

U2 - 10.1002/jbm.10044

DO - 10.1002/jbm.10044

M3 - Article

VL - 59

SP - 697

EP - 708

JO - Journal of Biomedical Materials Research

JF - Journal of Biomedical Materials Research

SN - 0021-9304

IS - 4

ER -